Aim The effect of 8 weeks' streptozotocin (STZ)-induced diabetes and aminoguanidine (AMNG), the inhibitor of advanced glycosylation reaction, treatment on arteriolar reactivity to vasoactive substances was investigated in vitro. Materials and Methods Studies were performed in untreated control rats (n=10), mg/kg i.v.) diabetic rats (n=10), AMNG-treated (600mg/1 given in drinking water throughout 8 weeks) control rats (n=10) and AMNG-treated (600mg/1 given in drinking water, beginning at 72h after STZ and throughout 8 weeks of diabetes) diabetic rats (n=10). Results are expressed as the mean 4-s.e. Relaxant responses are expressed as a percentage (%) relaxation of noradrenaline-induced tone. Statistical comparisons were made by one-way analysis of variance (ANOVA) followed by Tukey-Kramer multiple comparisons test.
INTRODUCTION
Hyperglycaemia is the primary cause of diabetic micro and macrovascular complications.
I1"2J
Several major mechanisms with resultant activation of protein kinase C (n 10). isoform. [3] [4] [5] [6] [7] Studies on vascular reactivity using the STZInduction of Experimental Diabetes diabetic rat have reported inconsistent results with increased, decreased and unchanged reRats were injected intravenously (into the lateral sponsiveness to noradrenaline, KC1, acetylchotail vein) with STZ (60mg/kg)(Sigma, S-0130, line and sodium nitroprusside. E1-14 Lot. 128H1045). STZ was freshly prepared in Today, in addition to the prevention of 0.25 ml saline. The rats were then maintained for hyperglycaemia by use of insulin and oral 8 animals. [45] In the dosage calculation, followed The present study was [10-14, 19, 20] response. It the majority of previous studies [22, [23] [24] [25] [26] [27] although others have reported no difference in vascular responsiveness to Ach in diabetic rats. [28, 29] The endothelium-dependent relaxant responses to agents such as acetylcholine are largely due to release of endothelium derived relaxing factor (EDRF). I301 EDRF is now considered to be identical to nitric oxide which is a key transducer of the vasodilator signalling. I30 , 31] Impaired endothelium-dependent relaxation in STZ-induced diabetic rat might be due to increased blood glucose level, decreased blood insulin level, decreased influx of Ca 2+ into endothelium or decreased release of Ca 2+ from its storage sites, a decreased content or inactivation of NO syntase and decreased diffusion of NO into the smooth muscle. 581 In addition, diabetes is believed to cause endothelial damage via oxidative stress which induces ROS and lipid peroxidation and a diabetes-induced functional change in vascular endothelial cells could be a key event in the development of the altered endothelium-dependent vasoreactivity. [32, 33] AMNG used in this study is a potential therapeutic agent for preventing the generation of advanced glycation end products in diabetes mellitus. [34] [39, 40] The majority of previous studies showed that the responsiveness to the endothelium-independent vasodilator, SNP, is not impaired in diabetics versus control [33'43-46] whilst some [41, 42] has demonstrated an impaired response. This study have also showed an unchanged sensitivity and a maximum relaxation to SNP in diabetics. Our results agree with the majority of previous studies. [33, [43] [44] [45] [46] The contractile response of the rat aorta to noradrenaline, a nonselective alpha agonist, is biphasic, consisting of a fast and a slow component. 47 The [48, 49] Despite the controversy concerning the effects of diabetes on the maximal response, sensitivity, fast and slow components of response to the alpha-adrenoceptor agonist, such as noradrenaline, [49] [50] [51] [52] most studies agree that agonist potency is not altered by diabetes. [20, [53] [54] [55] The present study has also demonstrated an unchanged sensitivity, a maximum contraction and its components to noradrenaline in diabetes. Our results are in agreement with some of the previous studies, t20, 53, 84, 58 The discrepancy between our results and those of other groups may be due to the different experiment protocols. In the present study, there were also no significant differences between the diabetic tissues and control tissues in the responsiveness to KC1. However, although some authors found conflicting results, 56 '57 the present results [28, 54] agree with those of other groups.
In conclusion, our study demonstrates that the chronic AMNG-treatment reversed the diminished vascular relaxation. However, its exact mechanism of action remain unclear and requires further investigation. 
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